Plus Therapeutics (PSTV) receives AMA CPT code for CNSide test, improving reimbursement pathways and clinical adoption amid 4 ...

Imbed Biosciences today announced that the Centers for Medicare & Medicaid Services (CMS) has assigned a Healthcare Common ...

Delivered strong topline performance with first quarter revenue expected to be $14.7 million to $14.8 million, approximately 20% growth compared ...

The dedicated billing code, 0640U, effective July 1, 2026, establishes a unique reimbursement identifier for the CNSide CSF TCE test, supporting payer claims processing and facilitating broader ...

Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain management MIDDLETON, Wis., April 1, 2026 /PRNewswire/ -- ...

The American Academy of Audiology annual conference is the premier event for audiology professionals, bringing together clinicians, researchers and industry leaders to explore the latest advancements ...

CEO Jim Clemmer used a presentation at Needham & Company’s 25th Annual Needham Healthcare Conference to outline the company’s ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system ...

Although one-stage exchange may effectively treat periprosthetic joint infection, results presented here showed reimbursement ...

From individual surgeon clawbacks to larger CMS repayment plans, insurance takebacks are reshaping the economics of medicine. For spine surgery, clawbacks have been a persistent area of friction, ...

Image-guided superficial radiation therapy remains a higher-cost treatment than Mohs surgery for nonmelanoma skin cancer, a retrospective study shows.